Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis
Raynaud’s Phenomenon (RP) leading to repetitive ischemia and reperfusion (IR) stress, is the first recognizable sign of systemic sclerosis (SSc) leading to increased oxidative stress. High-mobility group box-1 (HMGB1) is a nuclear factor released by apoptotic and necrotic cells after oxidative stres...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/12/4/794 |
| _version_ | 1797606637725286400 |
|---|---|
| author | Yehya Al-Adwi Isabella M. Atzeni Berber Doornbos-van der Meer Amaal Eman Abdulle Anniek M. van Roon Alja Stel Harry van Goor Andries J. Smit Johanna Westra Douwe J. Mulder |
| author_facet | Yehya Al-Adwi Isabella M. Atzeni Berber Doornbos-van der Meer Amaal Eman Abdulle Anniek M. van Roon Alja Stel Harry van Goor Andries J. Smit Johanna Westra Douwe J. Mulder |
| author_sort | Yehya Al-Adwi |
| collection | DOAJ |
| description | Raynaud’s Phenomenon (RP) leading to repetitive ischemia and reperfusion (IR) stress, is the first recognizable sign of systemic sclerosis (SSc) leading to increased oxidative stress. High-mobility group box-1 (HMGB1) is a nuclear factor released by apoptotic and necrotic cells after oxidative stress. Since HMGB1 can signal through the receptor for advanced glycation end products (RAGE), we investigated whether an RP attack promotes the release of HMGB1, leading to fibroblast activation and the upregulation of interferon (IFN)-inducible genes. A cold challenge was performed to simulate an RP attack in patients with SSc, primary RP (PRP), and healthy controls. We measured levels of HMGB1 and IFN gamma-induced Protein 10 (IP-10) at different time points in the serum. Digital perfusion was assessed by photoplethysmography. In vitro, HMGB1 or transforming growth factor (TGF-β1) (as control) was used to stimulate healthy human dermal fibroblasts. Inflammatory, profibrotic, and IFN-inducible genes, were measured by RT-qPCR. In an independent cohort, sera were obtained from 20 patients with SSc and 20 age- and sex-matched healthy controls to determine HMGB1 and IP-10 levels. We found that HMGB1 levels increased significantly 30 min after the cold challenge in SSc compared to healthy controls. In vitro stimulation with HMGB1 resulted in increased mRNA expression of IP-10, and interleukin-6 (IL-6) while TGF-β1 stimulation promoted IL-6 and Connective Tissue Growth Factor (CTGF). In serum, both HMGB1 and IP-10 levels were significantly higher in patients with SSc compared to healthy controls. We show that cold challenge leads to the release of HMGB1 in SSc patients. HMGB1 induces IP-10 expression in dermal fibroblasts partly through the soluble RAGE (sRAGE) axis suggesting a link between RP attacks, the release of HMGB1 and IFN-induced proteins as a putative early pathogenetic mechanism in SSc. |
| first_indexed | 2024-03-11T05:18:01Z |
| format | Article |
| id | doaj.art-75988b3ecbe04fab83e04140eaa80168 |
| institution | Directory Open Access Journal |
| issn | 2076-3921 |
| language | English |
| last_indexed | 2024-03-11T05:18:01Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Antioxidants |
| spelling | doaj.art-75988b3ecbe04fab83e04140eaa801682023-11-17T18:04:21ZengMDPI AGAntioxidants2076-39212023-03-0112479410.3390/antiox12040794Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis PathogenesisYehya Al-Adwi0Isabella M. Atzeni1Berber Doornbos-van der Meer2Amaal Eman Abdulle3Anniek M. van Roon4Alja Stel5Harry van Goor6Andries J. Smit7Johanna Westra8Douwe J. Mulder9Department of Internal Medicine, Division of Vascular Medicine, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsDepartment of Internal Medicine, Division of Vascular Medicine, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsDepartment of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsDepartment of Internal Medicine, Division of Vascular Medicine, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsDepartment of Internal Medicine, Division of Vascular Medicine, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsDepartment of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsDepartment of Pathology and Medical Biology, Section Pathology, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsDepartment of Internal Medicine, Division of Vascular Medicine, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsDepartment of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsDepartment of Internal Medicine, Division of Vascular Medicine, University Medical Centre Groningen, University of Groningen, 9700 RB Groningen, The NetherlandsRaynaud’s Phenomenon (RP) leading to repetitive ischemia and reperfusion (IR) stress, is the first recognizable sign of systemic sclerosis (SSc) leading to increased oxidative stress. High-mobility group box-1 (HMGB1) is a nuclear factor released by apoptotic and necrotic cells after oxidative stress. Since HMGB1 can signal through the receptor for advanced glycation end products (RAGE), we investigated whether an RP attack promotes the release of HMGB1, leading to fibroblast activation and the upregulation of interferon (IFN)-inducible genes. A cold challenge was performed to simulate an RP attack in patients with SSc, primary RP (PRP), and healthy controls. We measured levels of HMGB1 and IFN gamma-induced Protein 10 (IP-10) at different time points in the serum. Digital perfusion was assessed by photoplethysmography. In vitro, HMGB1 or transforming growth factor (TGF-β1) (as control) was used to stimulate healthy human dermal fibroblasts. Inflammatory, profibrotic, and IFN-inducible genes, were measured by RT-qPCR. In an independent cohort, sera were obtained from 20 patients with SSc and 20 age- and sex-matched healthy controls to determine HMGB1 and IP-10 levels. We found that HMGB1 levels increased significantly 30 min after the cold challenge in SSc compared to healthy controls. In vitro stimulation with HMGB1 resulted in increased mRNA expression of IP-10, and interleukin-6 (IL-6) while TGF-β1 stimulation promoted IL-6 and Connective Tissue Growth Factor (CTGF). In serum, both HMGB1 and IP-10 levels were significantly higher in patients with SSc compared to healthy controls. We show that cold challenge leads to the release of HMGB1 in SSc patients. HMGB1 induces IP-10 expression in dermal fibroblasts partly through the soluble RAGE (sRAGE) axis suggesting a link between RP attacks, the release of HMGB1 and IFN-induced proteins as a putative early pathogenetic mechanism in SSc.https://www.mdpi.com/2076-3921/12/4/794injuryischemia and reperfusionRaynaud’s phenomenonSScIP-10HMGB1 |
| spellingShingle | Yehya Al-Adwi Isabella M. Atzeni Berber Doornbos-van der Meer Amaal Eman Abdulle Anniek M. van Roon Alja Stel Harry van Goor Andries J. Smit Johanna Westra Douwe J. Mulder Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis Antioxidants injury ischemia and reperfusion Raynaud’s phenomenon SSc IP-10 HMGB1 |
| title | Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis |
| title_full | Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis |
| title_fullStr | Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis |
| title_full_unstemmed | Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis |
| title_short | Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis |
| title_sort | release of high mobility group box 1 after a raynaud s attack leads to fibroblast activation and interferon γ induced protein 10 production role in systemic sclerosis pathogenesis |
| topic | injury ischemia and reperfusion Raynaud’s phenomenon SSc IP-10 HMGB1 |
| url | https://www.mdpi.com/2076-3921/12/4/794 |
| work_keys_str_mv | AT yehyaaladwi releaseofhighmobilitygroupbox1afteraraynaudsattackleadstofibroblastactivationandinterferonginducedprotein10productionroleinsystemicsclerosispathogenesis AT isabellamatzeni releaseofhighmobilitygroupbox1afteraraynaudsattackleadstofibroblastactivationandinterferonginducedprotein10productionroleinsystemicsclerosispathogenesis AT berberdoornbosvandermeer releaseofhighmobilitygroupbox1afteraraynaudsattackleadstofibroblastactivationandinterferonginducedprotein10productionroleinsystemicsclerosispathogenesis AT amaalemanabdulle releaseofhighmobilitygroupbox1afteraraynaudsattackleadstofibroblastactivationandinterferonginducedprotein10productionroleinsystemicsclerosispathogenesis AT anniekmvanroon releaseofhighmobilitygroupbox1afteraraynaudsattackleadstofibroblastactivationandinterferonginducedprotein10productionroleinsystemicsclerosispathogenesis AT aljastel releaseofhighmobilitygroupbox1afteraraynaudsattackleadstofibroblastactivationandinterferonginducedprotein10productionroleinsystemicsclerosispathogenesis AT harryvangoor releaseofhighmobilitygroupbox1afteraraynaudsattackleadstofibroblastactivationandinterferonginducedprotein10productionroleinsystemicsclerosispathogenesis AT andriesjsmit releaseofhighmobilitygroupbox1afteraraynaudsattackleadstofibroblastactivationandinterferonginducedprotein10productionroleinsystemicsclerosispathogenesis AT johannawestra releaseofhighmobilitygroupbox1afteraraynaudsattackleadstofibroblastactivationandinterferonginducedprotein10productionroleinsystemicsclerosispathogenesis AT douwejmulder releaseofhighmobilitygroupbox1afteraraynaudsattackleadstofibroblastactivationandinterferonginducedprotein10productionroleinsystemicsclerosispathogenesis |